Skip to content

Telemedicine versus in-person consultation for major mental illness.

Efficacy of telemedicine consultation compared to in-person consultation for patients with major mental illness: An open-label randomised control trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090684
Enrollment
496
Registered
2025-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F42- Obsessive-compulsive disorder Health Condition 2: F20- Schizophrenia Health Condition 3: F31- Bipolar disorder Health Condition 4: F32- Major depressive disorder, singleepisode

Interventions

Intervention1: Telemedicine: Participants randomized to telemedicine arm will be provided telemedicine mode of consultation at 15th day (1st follow-up) and 30th day (2nd follow-up) for their mental il

Sponsors

Multidisciplinary Research Unit MRU of AIIMS Deoghar under DHR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients diagnosed with major mental illness like Schizophrenia Bipolar Disorder Major Depressive Disorder and OCD were diagnosed using ICD 11. Able to provide written informed consent. Having Mobile phone with WhatsApp facility.

Exclusion criteria

Exclusion criteria: Patients with severe disease as determined by requiring inpatient care or referral to a higher centre for intervention.

Design outcomes

Primary

MeasureTime frame
1. change in CGI-S scores at all consultations to assess severity.Timepoint: Baseline, 15th, 30th, 45th day

Secondary

MeasureTime frame
1. Change in Positive and Negative symptoms scale (PANSS) scores for schizophrenia. 2. Change in Hamilton rating scale for depression (HAM-D) for Depression. 3. Change in Yale-Brown obsessive-compulsive scale (Y-BOCS) for OCD. 4. Change in Young mania rating scale (YMRS) for Mania. 5. cost-effectiveness, patient satisfaction, and treatment adherence across the various time points.Timepoint: Baseline, 15th, 30th, 45th day

Countries

India

Contacts

Public ContactSantanu Nath

All India Institute of Medical Sciences-Deoghar

doc.santanunath@gmail.com9337434349

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026